CNBX Stock, Cannabics Pharmaceuticals Inc Information

Cannabics Pharmaceuticals Inc. CNBX , is dedicated to the development of personalized diagnostic tools to provide supportive data for practitioners and patients regarding cannabinoid based cancer therapy. The Company s R amp D is based in Israel, where it is fully licensed by the Ministry of Health and involves both scientific and current medical clinical studies which are registered with the US NIH. Cannabics is now creating tailored therapies for cancer patients, utilizing advanced Liquid Biopsy and HTS technology along with personalized bioinformatics tools. Cannabics research is devoted to the discovery of cannabinoid compounds targeted to specific cancers based on the confluence of cutting edge technologies and personalized bioinformatic markers.